3.68 USD
+0.01 (+0.27%)
3.61 USD
-0.07 (-1.9%)
LRMR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. The financial health of LRMR is average, but there are quite some concerns on its profitability. LRMR is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year LRMR has reported negative net income.
- In the past year LRMR has reported a negative cash flow from operations.
- In the past 5 years LRMR always reported negative net income.
- LRMR had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- LRMR's Return On Assets of -70.46% is on the low side compared to the rest of the industry. LRMR is outperformed by 62.86% of its industry peers.
- LRMR has a Return On Equity (-94.94%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -70.46% | ||
| ROE | -94.94% | ||
| ROIC | N/A |
ROA(3y)-35.58%
ROA(5y)-42.34%
ROE(3y)-41.34%
ROE(5y)-50%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for LRMR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, LRMR has more shares outstanding
- LRMR has more shares outstanding than it did 5 years ago.
- LRMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -0.46, we must say that LRMR is in the distress zone and has some risk of bankruptcy.
- LRMR's Altman-Z score of -0.46 is in line compared to the rest of the industry. LRMR outperforms 57.71% of its industry peers.
- LRMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.46 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- LRMR has a Current Ratio of 4.06. This indicates that LRMR is financially healthy and has no problem in meeting its short term obligations.
- LRMR has a Current ratio of 4.06. This is comparable to the rest of the industry: LRMR outperforms 48.57% of its industry peers.
- A Quick Ratio of 4.06 indicates that LRMR has no problem at all paying its short term obligations.
- The Quick ratio of LRMR (4.06) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.06 | ||
| Quick Ratio | 4.06 |
3. Growth
3.1 Past
- The earnings per share for LRMR have decreased strongly by -67.83% in the last year.
EPS 1Y (TTM)-67.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-154.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- LRMR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.79% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-54.11%
EPS Next 2Y-21.29%
EPS Next 3Y-8.17%
EPS Next 5Y-6.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- LRMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year LRMR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- LRMR's earnings are expected to decrease with -8.17% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.29%
EPS Next 3Y-8.17%
5. Dividend
5.1 Amount
- LRMR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LARIMAR THERAPEUTICS INC / LRMR FAQ
What is the fundamental rating for LRMR stock?
ChartMill assigns a fundamental rating of 2 / 10 to LRMR.
What is the valuation status for LRMR stock?
ChartMill assigns a valuation rating of 0 / 10 to LARIMAR THERAPEUTICS INC (LRMR). This can be considered as Overvalued.
What is the profitability of LRMR stock?
LARIMAR THERAPEUTICS INC (LRMR) has a profitability rating of 0 / 10.
What is the earnings growth outlook for LARIMAR THERAPEUTICS INC?
The Earnings per Share (EPS) of LARIMAR THERAPEUTICS INC (LRMR) is expected to decline by -54.11% in the next year.